M759-3110 Screening compound: 1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine

M759-3110 Screening compound: 1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine
M759-3110 Screening compound: 1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound M759-3110
1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M759-3110

Molecular Formula

C15H21N5O2S (C15 H21 N5 O2 S)

Compound Name

1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine

IUPAC name

1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine

SMILES

CCn1ncc(S(N(C2)CC2N(C)Cc2cnccc2)(=O)=O)c1

InChI

InChI=1S/C15H21N5O2S/c1-3-19-12-15(8-17-19)23(21,22)20-10-14(11-20)18(2)9-13-5-4-6-16-7-13/h4-8,12,14H,3,9-11H2,1-2H3

InChI Key

DXDMUNQYHCLYSW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29014119

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

335.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

-0.311

Distribution Coefficient, logD

-0.496

Water Solubility, LogSw

-1.38

Polar Surface Area

58.763

Acid Dissociation Constant (pKa)

26.07

Base Dissociation Constant (pKb)

7.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.70

M759-3110 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

KRAS-Targeted Library (16000 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
Targets:
  • Kinases
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with M759-3110 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M759-3110?
Check Price and Availability of M759-3110, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M759-3110 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M759-3110
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M759-3110
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M759-3110 available by request